33514-20-4

Basic information

• Product Name: 2,6-dibenzylidene-4-methyl-cyclohexanone
• CAS NO: 33514-20-4
• Molecular Weight: 288.389
• Mol File: 33514-20-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2,6-dibenzylidene-4-methyl-cyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-dibenzylidene-4-methyl-cyclohexanone(33514-20-4)
• EPA Substance Registry System: 2,6-dibenzylidene-4-methyl-cyclohexanone(33514-20-4)

Safety Data

• Hazardous Substances Data: 33514-20-4(Hazardous Substances Data)

Upstream product

• 141-52-6 sodium ethanolate 
• 100-52-7 benzaldehyde 
• 589-92-4 1-methylcyclohexan-4-one 
• 64-17-5 ethanol 
• 62-53-3 aniline 
• 7664-41-7 ammonia 
• 5601-45-6 4-(4-methylcyclohex-1-en-1-yl)morpholine 
• 589-91-3 p-methylcyclohexanol 

Downstream Products

• 1427056-62-9 5-benzylidene-3,3,7-trimethyl-9-phenyl-3,4,5,6,7,8-hexahydro-2H-xanthen-1(9H)-one 
• 18013-02-0 5-Methyl-dihydropyrogallol 

Relevant articles and documents

Structure activity relationship analysis of antiproliferative cyclic C5-curcuminoids without DNA binding: Design, synthesis, lipophilicity and biological activity

The chemical susceptibility of the β-diketone linker between the two aromatic rings in the structure of curcumin to hydrolysis and metabolism has made it crucial to investigate structurally modified analogs of curcumin without such shortcomings. The synth

Claisen-schmidt condensation catalyzed by metal-organic frameworks

Metal-organic framework [Fe(BTC) (BTC = 1,3,5-benzenetricarboxylic acid)] is a convenient heterogeneous catalyst for the carbon-carbon bond forming reaction in toluene between acetophenone and benzaldehyde to give selectively chalcone in high yield. Fe(BTC) appears as a general catalyst able to synthesize selectively different chalcone derivatives bearing various functionalities. Fe(BTC) could be recycled with no significant loss of catalytic efficiency and crystallinity in subsequent runs.

2-Heterocyclicalkyl-3,3a,4,5,6,7-hexahydro-3-phenyl-7-(phenylmethylene)-2H-indazoles

Compounds of the formula STR1 wherein R, X1, X2, A and B are as defined herein, and their N-oxides and acid addition salts thereof, are provided which have been found to possess anti-inflammatory activity. In addition, methods for preparing such compounds, pharmaceutical compositions containing such compounds, and methods for using such compositions as anti-inflammatory agents are also provided.